Schrödinger

Update in progress

SDGR (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryHealth Information Services

Schrödinger, Inc. and its subsidiaries develop a physics-based computational platform that enables discovery of novel molecules for drug development and materials research worldwide. The company has two segments: Software, which markets tools to advance molecular discovery in life sciences and materials science; and Drug Discovery, which builds a portfolio of preclinical and clinical programs through internal efforts and collaborations. It has a research collaboration and license with Novartis to advance multiple development candidates. Incorporated in 1990 and based in New York, NY.

Company score

Sentiment: 0.12; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.09; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.13; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.07; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.05; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNasdaqGS (NMS)
LocationUnited States
CEODr. Ramy Farid Ph.D.
Founded1990
Employees850
Websitewww.schrodinger.com

Identifiers

ISINUS80810D1037
FIGIBBG000T88BN2
CUSIP80810D103
CIK0001490978